A randomized clinical trial on inhaled ciclesonide for managing acute asthma in the emergency room.
Sao Paulo medical journal = Revista paulista de medicina · 2022-01-01 · Randomised trial
Abstract
BACKGROUND: Use of inhaled corticosteroids for managing acute asthma exacerbations has been tested since the 1990s. OBJECTIVE: To compare high doses of inhaled ciclesonide with systemic hydrocortisone for managing acute asthma exacerbations in the emergency department. DESIGN AND SETTING: Double-blind, randomized clinical trial in the public healthcare system of the city of São Paulo. METHODS: Fifty-eight patients with moderate or severe asthma with peak flow < 50% of predicted were randomized into two groups. Over the course of four hours, one group received 1440 mcg of inhaled ciclesonide plus hydrocortisone-identical placebo (ciclesonide + placebo), while the other received 500 mg of intravenous hydrocortisone plus ciclesonide-identical placebo (hydrocortisone + placebo). Both groups received short-acting bronchodilators (fenoterol hydrobromide and ipratropium bromide). The research protocol included spirometry, clinical evaluation, vital signs and electrocardiogram monitoring. Data were obtained at 30 (baseline), 60, 90, 120, 180, and 240 minutes. We compared data from baseline to hour 4, between and within groups. RESULTS: Overall, 31 patients received ciclesonide + placebo and 27 received hydrocortisone + placebo. Inhaled ciclesonide was as effective as intravenous hydrocortisone for improving clinical parameters (Borg-scored dyspnea, P = 0.95; sternocleidomastoid muscle use, P = 0.55; wheezing, P = 0.55; respiratory effort, P = 0.95); and spirometric parameters (forced vital capacity, P = 0.50; forced expiratory volume in the first second, P = 0.83; peak expiratory flow, P = 0.51). CONCLUSIONS: Inhaled ciclesonide was not inferior to systemic hydrocortisone for managing acute asthma exacerbations, and it improved both clinical and spirometric parameters. TRIAL REGISTRATION: RBR-6XWC26 - Registro Brasileiro de Ensaios Clínicos (http://www.ensaiosclinicos.gov.br/rg/RBR-6xwc26/).
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Corticosteroids · Hydrocortisone · Inhaled corticosteroids · Respiratory drugs
Related articles
- Nebulized budesonide combined with systemic corticosteroid vs systemic corticosteroid alone in acute severe asthma managed in the emergency department: a randomized controlled trial. (BMC Emerg Med, 2022)
- Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. (Am J Respir Crit Care Med, 2005)
- Inhaled Corticosteroids in Acute Asthma: A Systemic Review and Meta-Analysis. (J Allergy Clin Immunol Pract, 2020)
- Effectiveness of inhaled corticosteroids in the treatment of acute asthma in children in the emergency department: a meta-analysis. (Ann Med, 2014)
- Inhaled versus systemic corticosteroids for acute asthma in children. A systematic review. (Pediatr Pulmonol, 2014)
- Inhaled steroids in acute asthma following emergency department discharge. (Cochrane Database Syst Rev, 2000)